tirzepatide novo nordisk F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Watch out for fake versions

More research is needed to fully understand why this happens

in TCC, GSTP1 should be considered as a potential therapeutic target This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

17%, PR 1.30 [95% CI 1.16-1.46])

If you return the item within 30 days, we will refund you the full purchase price

Bottom line: While dizziness can be an unsettling side effect of Wegovy, it is typically manageable through simple lifestyle adjustments and close communication with your healthcare provider